Skip to content

ACS:180 and Advia Centaur Ipth Immunoassay

by Bayer Diagnostics Corp.

510(k) K020217

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

4 closed

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK020217 Date15 Mar 2002ClearedStatusActive

Recalls

4 recalls · FDA

    • Terminated Z-0173-2014 FDA Class III initiated 16 Aug 2013 on shared 510(k) K020217

    PTH Calibrator packaged with only high calibrator.

  • 2 recalls, same reason

    • Terminated Z-1515-2013 FDA Class II initiated 14 May 2013 on shared 510(k) K020217
    • Terminated Z-1514-2013 FDA Class II initiated 14 May 2013 on shared 510(k) K020217

    iPTH Assay- reagent and calibrator lots may have demonstrated higher than anticipated variability

    • Terminated Z-1186-2012 FDA Unclassified (pre-2012) initiated 3 Oct 2008 on shared 510(k) K020217

    Poor sensitivity and imprecision on ADVIA Centaur systems; Serum samples low bias; EDTA plasma samples low bias

Recalls on a shared submission name another device cleared under the same FDA submission as this one.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
JJX
Device Class
Class I
Regulation
21 CFR Part 862.1660
Advisory Committee
Clinical Chemistry
FDA Decision
SESE Substantially Equivalent

Other devices from Bayer Diagnostics Corp.

See all devices from Bayer Diagnostics Corp. →